Literature DB >> 2040271

Isolation and characterization of the human pyruvate kinase M gene.

M Takenaka1, T Noguchi, S Sadahiro, H Hirai, K Yamada, T Matsuda, E Imai, T Tanaka.   

Abstract

Genomic clones containing the human pyruvate kinase M (PKM) gene, which encodes the M1-type and M2-type isozymes, were isolated and their exon sequences were determined. The gene is approximately 32 kb and consists of 12 exons and 11 introns. Exons 9 and 10 contain sequences specific to the M1 and M2 types, respectively, indicating that the human isozymes are produced from the same gene by alternative splicing as in the case of the rat gene. The exon-intron structure of the human PKM gene is identical to that of the rat gene, and the introns of both genes interrupt the exons at the same points. Introns 6 and 7 begin with GC dinucleotide instead of the consensus GT, but the other exon-intron boundaries are consistent with the GT-AG rule. The gene is transcribed from multiple start sites. The 5'-flanking region of the gene contains putative Sp1-binding sites, but no TATA box or CAAT box, and shows high sequence similarity to that of the rat M gene. Bacterial chloramphenicol acetyltransferase assay revealed that the upstream region between positions -493 and -51 contained a cis-acting element(s) that was essential for expression of the M gene in HeLa cells. Long stretches of conserved regions were found in the introns around the M1-specific and M2-specific exons, suggesting that these regions may be involved in the alternative splicing machinery.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040271     DOI: 10.1111/j.1432-1033.1991.tb15991.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  34 in total

1.  Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase.

Authors:  Jian-kang Jiang; Matthew B Boxer; Matthew G Vander Heiden; Min Shen; Amanda P Skoumbourdis; Noel Southall; Henrike Veith; William Leister; Christopher P Austin; Hee Won Park; James Inglese; Lewis C Cantley; Douglas S Auld; Craig J Thomas
Journal:  Bioorg Med Chem Lett       Date:  2010-04-11       Impact factor: 2.823

2.  Concentration-dependent control of pyruvate kinase M mutually exclusive splicing by hnRNP proteins.

Authors:  Mo Chen; Charles J David; James L Manley
Journal:  Nat Struct Mol Biol       Date:  2012-02-05       Impact factor: 15.369

Review 3.  Human pyruvate kinase M2: a multifunctional protein.

Authors:  Vibhor Gupta; Rameshwar N K Bamezai
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

Review 4.  Pyruvate kinase: Function, regulation and role in cancer.

Authors:  William J Israelsen; Matthew G Vander Heiden
Journal:  Semin Cell Dev Biol       Date:  2015-08-13       Impact factor: 7.727

5.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

Review 6.  Metabolic modulation of cancer: a new frontier with great translational potential.

Authors:  Adam Kinnaird; Evangelos D Michelakis
Journal:  J Mol Med (Berl)       Date:  2015-01-14       Impact factor: 4.599

Review 7.  Pyruvate kinase M2: A simple molecule with complex functions.

Authors:  Mohammed Alquraishi; Dexter L Puckett; Dina S Alani; Amal S Humidat; Victoria D Frankel; Dallas R Donohoe; Jay Whelan; Ahmed Bettaieb
Journal:  Free Radic Biol Med       Date:  2019-08-08       Impact factor: 7.376

8.  Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages.

Authors:  Eva M Palsson-McDermott; Anne M Curtis; Gautam Goel; Mario A R Lauterbach; Frederick J Sheedy; Laura E Gleeson; Mirjam W M van den Bosch; Susan R Quinn; Raquel Domingo-Fernandez; Daniel G W Johnston; Jian-Kang Jiang; Jain-Kang Jiang; William J Israelsen; Joseph Keane; Craig Thomas; Clary Clish; Matthew Vander Heiden; Matthew Vanden Heiden; Ramnik J Xavier; Luke A J O'Neill
Journal:  Cell Metab       Date:  2015-01-06       Impact factor: 27.287

9.  Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.

Authors:  Matthew B Boxer; Jian-kang Jiang; Matthew G Vander Heiden; Min Shen; Amanda P Skoumbourdis; Noel Southall; Henrike Veith; William Leister; Christopher P Austin; Hee Won Park; James Inglese; Lewis C Cantley; Douglas S Auld; Craig J Thomas
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

10.  Glycolytic enzymes of Candida albicans are nonubiquitous immunogens during candidiasis.

Authors:  R K Swoboda; G Bertram; H Hollander; D Greenspan; J S Greenspan; N A Gow; G W Gooday; A J Brown
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.